Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

June 10, 2014

Why Big Pharma Needs Blockbusters

Orphan drugs are one way it aims to get them.

Why Big Pharma Needs Blockbusters

Orphan drugs—drugs for rare diseases—can be blockbusters if priced high enough. [© Orlando Florin Rosu - Fotolia.com]

The word “blockbuster” is reserved for drugs with over one billion dollars in yearly sales From big pharma’s own discovery and development (DD&D) data, even blockbusters could lose money Profitability depends significantly on an intangible, the discount rate used to calculate net present value (NPV)...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.

Related content